A. Takeshita et al., TRAM-1, A NOVEL 160-KDA THYROID-HORMONE RECEPTOR ACTIVATOR MOLECULE, EXHIBITS DISTINCT PROPERTIES FROM STEROID-RECEPTOR COACTIVATOR-1, The Journal of biological chemistry, 272(44), 1997, pp. 27629-27634
Nuclear hormone receptors (NRs) are ligand-dependent transcription fac
tors that regulate target gene transcription, We report the molecular
cloning and characterization of a novel human cDNA encoding TRAM-1, a
thyroid hormone receptor activator molecule, a similar to 160-kDa prot
ein homologous with SRC-1/TIF2, by far-Western-based expression screen
ing. TRAM-1 binds to thyroid hormone receptor (TR) and other NRs in a
ligand-dependent manner and enhances ligand-induced transcriptional ac
tivity of TR. The AF-2 region in NRs has been thought to play a critic
al role in mediating ligand-dependent transactivation by the interacti
on with coactivators. Surprisingly, TRAM-1 retains strong ligand-depen
dent interaction with an AF-2 mutant of TR (E457A), while SRC-1 fails
to interact with this mutant. Furthermore, we identified a critical TR
AM-1 binding site in rat TR beta 1 outside of AF-2, as TRAM-1 shows we
ak ligand-dependent interaction with a helix 3 ligand binding domain T
R mutant (K288A), compared with SRC-1. These results suggest that TRAM
-1 is a coactivator that may exhibit its activity by interacting with
subdomains of NRs other than the AF-2 region, in contrast to SRC-1/TIF
2.